You've seen the slick demos: "AI-powered telehealth saves employees time and money." Symptom checkers, virtual triage, auto-routing to specialists. It all sounds like a no-brainer.
But behind that glossy patient app, something else is brewing, something most benefits leaders haven't caught yet. AI telehealth platforms aren't just another vendor in your stack. They're quietly reshaping how claims get processed, how risk gets distributed, and how fiduciary responsibility lands on your desk.
After years helping self-funded employers design and audit their benefits tech, I've spotted three rarely discussed risks that deserve your attention before your next renewal.
1. The Prior Authorization Black Box
Traditional prior authorization flows from provider to plan-slow, manual, and a headache for everyone. AI telehealth platforms promise to automate this with "clinical decision support." The algorithm sizes up the patient, builds a summary, and shoots the PA request to the plan automatically.
Sounds efficient. But there's a catch: The AI is making coverage-adjacent decisions without being the one who answers for them.
When the platform decides a rash is "low-acuity" and kicks the PA request to a telehealth dermatologist, it's effectively pre-adjudicated that claim. If the employee later sees a different in-network dermatologist for the same rash, the plan may slap a "duplicate" flag on it. The employee gets a denial letter that makes no sense. You get the angry phone call.
Worse, some AI platforms "learn" from past PA approvals and start mimicking plan preferences-without ever telling you or the TPA what their algorithm is doing. That's a regulatory gray zone under ERISA Section 503, which requires a full and fair review of every adverse benefit determination. Federal guidance on how that standard applies to AI-driven claims is still unwritten. If the AI narrows what "medical necessity" means beyond what your plan document says, you're on the hook, not the platform.
What you can do:
- Ask your telehealth vendor for a PA transparency report: How often does the AI recommend against submitting a PA? What clinical criteria does it lean on?
- Demand a clear employee appeals process that separates AI-driven denials from plan-based denials.
2. The Silent Redistribution of Network Risk
Most AI telehealth platforms plug into big PPO networks. But the part nobody talks about: The AI routes patients to specific providers based on availability, cost, or satisfaction scores-not network adequacy standards.
For self-funded employers, this creates a sneaky concentration risk. If your AI platform consistently steers employees to a small handful of providers (because their systems play nicely together), your claims data gets clustered around those few entities.
Stop-loss carriers underwrite expected claim fluctuation based on broad, random utilization. When care gets centralized, the correlation risk shoots up. One bad quarter from a single provider group can blow through your specific stop-loss attachment point.
I've seen this happen. One employer found that nearly all of its telehealth specialist referrals were flowing to a single corporate practice of medicine group, and the stop-loss renewal came back higher as a result. The employer had no idea the concentration existed.
What you can do:
- Pull network utilization reports by provider TIN for all telehealth encounters.
- If you see heavy concentration, ask the platform for a "network diversification commitment" in the contract.
- Request de-identified routing logic so you can model the stop-loss impact yourself.
3. The New Compliance Frontier: AI as a Fiduciary Function
Under ERISA, plan fiduciaries have to act prudently and solely in the interest of participants, and that duty includes monitoring the vendors they hire. When you pick an AI telehealth platform that automatically denies certain appointment types based on some proprietary algorithm, are you still meeting that duty?
One scenario keeps me up at night: An AI triages a diabetic employee with a mild foot ulcer as "low risk" and recommends a text-based nurse consult instead of a podiatrist visit. The employee follows that advice. The ulcer gets worse. The plan ends up paying far more for the resulting emergency visit and hospital stay than a podiatrist visit would have cost. The employee sues for breach of fiduciary duty, arguing you "knew or should have known" the AI wasn't cut out for chronic conditions.
This theory is already being tested. In the Cigna PxDx litigation, participants alleged an ERISA fiduciary breach because an algorithm reviewed claims without the individual medical-director review the plan promised, and a federal judge let the case move forward in 2025. Employers get named under the same logic when they haven't done their homework on a platform's clinical validation for populations with comorbidities. Many platforms also invoke trade secret protections to resist showing how their models work, which makes that homework harder.
What you can do before signing or renewing:
- Ask for clinical validation studies for the conditions most common in your workforce-musculoskeletal, mental health, diabetes.
- Request a bias audit: Does the AI under-recommend specialist care for certain demographic groups? If the AI treats mental health differently from physical health, that's a non-quantitative treatment limitation that can trip MHPAEA.
- Get a fiduciary risk disclosure that spells out any automatic deferral or denial logic that could override a patient's clinical judgment or plan benefits.
AI Denial Litigation Is Already Underway
None of this is hypothetical. Since 2023, courts and regulators have been testing exactly these questions.
In November 2023, families of deceased Medicare Advantage members sued UnitedHealth Group over nH Predict, a naviHealth tool that estimated how long patients should need post-acute care. The complaint alleged the algorithm overrode treating physicians and cut coverage early. A Senate subcommittee's October 2024 report found UnitedHealth's denial rate for post-acute care claims more than doubled after the tool was deployed, and in 2026 a federal judge ordered the company to hand over broad discovery.
Cigna faces a parallel case over its PxDx tool. After a ProPublica report that the algorithm batch-denied roughly 300,000 claims in two months, with doctors averaging 1.2 seconds per review, participants filed a class action in 2023 alleging an ERISA fiduciary breach. In March 2025 a federal judge let the case proceed.
Regulators are moving too. The NAIC adopted a model bulletin on AI use by insurers in December 2023, and states have been adopting it since. CMS told Medicare Advantage plans in February 2024 that AI may assist coverage decisions but cannot override medical necessity or ignore the individual patient's record. California's Physicians Make Decisions Act took effect on January 1, 2025, barring insurers from relying solely on AI to deny care on medical necessity grounds, and Texas passed a similar law in 2025.
For a self-funded plan, the lesson is direct: the same conduct is being litigated as a fiduciary failure. If your telehealth vendor's AI is making decisions that shape coverage, assume the questions asked in these cases will be asked of your plan next.
The Bottom Line
AI telehealth isn't just a jazzy add-on to your benefits strategy. It's quietly rewriting how care gets triaged, routed, and adjudicated. If you treat it like any other vendor, you'll miss the structural shifts that can spike your stop-loss premiums, create invisible PA denials, and open you up to fiduciary liability.
The one question you should ask yourself: Not "Does our telehealth AI save money?" but "How does our telehealth AI change the risk profile of our plan's claims, networks, and compliance posture?"
The platforms are powerful. But the infrastructure they run on was built for a different era. As a benefits leader, your job is to rebuild that foundation-starting with the invisible architecture underneath the patient's screen.
Want a one-page vendor assessment checklist for AI telehealth platforms? Reach out-I'll share the due diligence framework I use with clients.
This article is for general information only and is not legal, tax, or medical advice. Employers should consult their own advisors.